TY - JOUR
T1 - When insulin has to work hard to keep the sugar at bay the upper airway collapses away
AU - Eckert, Danny J.
AU - Oliven, Arie
PY - 2016/6/1
Y1 - 2016/6/1
N2 - Obesity is a major risk factor for both obstructive sleep apnoea (OSA) and metabolic disease. As obesity rates continue to rise, so too does the prevalence of OSA and metabolic disorders. Indeed, recent community sample data from over 2000 adults aged 40–85 years in Switzerland indicate that up to 50% of men and almost a quarter of women have apnoea–hypopnoea indices (AHI) within the moderate to severe range (>15 events·h−1 sleep) [1]. Insulin resistance, a strong predictor for the development of type 2 diabetes [2], is being recognised earlier with prevalence rates in children varying between 3 and 44% [3]. Thus, OSA and insulin resistance are major health issues.
AB - Obesity is a major risk factor for both obstructive sleep apnoea (OSA) and metabolic disease. As obesity rates continue to rise, so too does the prevalence of OSA and metabolic disorders. Indeed, recent community sample data from over 2000 adults aged 40–85 years in Switzerland indicate that up to 50% of men and almost a quarter of women have apnoea–hypopnoea indices (AHI) within the moderate to severe range (>15 events·h−1 sleep) [1]. Insulin resistance, a strong predictor for the development of type 2 diabetes [2], is being recognised earlier with prevalence rates in children varying between 3 and 44% [3]. Thus, OSA and insulin resistance are major health issues.
KW - Obesity
KW - obstructive sleep apnoea
KW - metabolic disorders
UR - http://purl.org/au-research/grants/NHMRC/1049814
UR - http://www.scopus.com/inward/record.url?scp=84973487307&partnerID=8YFLogxK
U2 - 10.1183/13993003.00590-2016
DO - 10.1183/13993003.00590-2016
M3 - Editorial
VL - 47
SP - 1611
EP - 1614
JO - The European Respiratory Journal
JF - The European Respiratory Journal
SN - 1399-3003
IS - 6
ER -